Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02113085 · ClinicalTrials.gov registry record · NA

My Life: Evaluation of Self-determination Enhancement for Adolescents in Foster Care

A NA study of Mental Disorders, sponsored by Portland State University.

Completed
Registry status
NA
Development phase
186
Enrollment target
1
Study location

NCT02113085: Completed NA study of Mental Disorders, sponsored by Portland State University.

NCT02113085 is a NA study of Mental Disorders that has completed, run by Portland State University. The registered enrollment target is 186 participants, below the 677-participant average among 25 other Mental Disorders trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02113085, a NA study of Mental Disorders, has completed, sponsored by Portland State University.

COMPLETED
Registry status
NA
Development phase
186 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to implement a full-scale efficacy trial of the My Life program. Conducted in partnership with the Oregon DHS Foster Care Program, the impact of the intervention will be being evaluated with a randomized experimental longitudinal design. Two hundred and ten youth, ages 16.5-17.5, will be enrolled in 3 waves, and randomly assigned to either a comparison group that receives typical foster care services or to a treatment group that participates in the key elements of the model, including instruction in self-determination skills, support in leading their own coordinated inter-agency transition planning meetings, and participation in workshops with mentors. Outcomes, including youth self-determination, quality of life, employment, mental health, educational achievement and independent living, are assessed pre-intervention, at the conclusion of intervention, and at 12 months post-intervention. The proposed study will provide important information on the efficacy of the model for all youth exiting the foster care system, yielding unequivocal data on whether enhanced self-determination mediates, at least partially, various outcome areas, including mental health, educational achievement, employment, independent living, and quality of life; evaluating the effect of special education status, gender, and race as moderating influences on the impact of the intervention. Foster care experiences, such as trauma and placement instability, will be considered as covariates; direct effects of the intervention on these key foster care experiences will also be explored.

Primary Outcome

The Arc (Wehmeyer, 1996; Wehmeyer \& Kelchner, 1995) is a 72-item self-report measure that provides data on four components self-determination as well as providing a global overall score of self-determination.

Conditions Studied

Interventions

  • BEHAVIORAL Self-determination enhancement

Study Locations (1)

Oregon

  • Oregon DHS - Portland

Trial Details

FieldValue
Enrollment Target 186 participants
Start Date 2012-02
Est. Completion 2015-12
Phase NA
Portland State University

6 total trials

What the finished NCT02113085 record still lists

NCT02113085 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 677-participant average among 25 other Mental Disorders trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Mental Disorders appearing as the primary indexed condition, and to 1 intervention - of which Self-determination enhancement is the first listed.

NCT02113085 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT02113085 about?

NCT02113085 is a clinical study titled "My Life: Evaluation of Self-determination Enhancement for Adolescents in Foster Care". The purpose of the study is to implement a full-scale efficacy trial of the My Life program. Conducted in partnership with the Oregon DHS Foster Care Program, the impact of the intervention will be being evaluated with a randomized experimental longitudinal design. Two hundred and ten youth, ages 16...

What is the current status of trial NCT02113085?

This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2012-02. Estimated completion is 2015-12.

What conditions does trial NCT02113085 study?

This clinical trial studies the following conditions: Mental Disorders.

What interventions are being tested in trial NCT02113085?

The interventions under investigation include: Self-determination enhancement (BEHAVIORAL).

Who is sponsoring clinical trial NCT02113085?

This trial is sponsored by Portland State University, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02113085 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02113085's enrollment target sits among peer trials

186 15th of 25 higher than 11 of 25 other Mental Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03567889 · 186 participants · Phase 3

    Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  • NCT05281471 · 186 participants · Phase 3

    Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

  • NCT05405595 · 186 participants · Phase 1

    ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

  • NCT05762107 · 186 participants · Phase 2

    A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02113085, the US trial registry maintained by the National Library of Medicine. NCT02113085 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.